The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, efficacy and biomarker data in patients with non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab in combination with platinum doublet.
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Janssen; Lilly; Medscape; Merck Serono; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Regeneron; Roche/Genentech; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); Pfizer (Inst); PharmaMar (Inst)
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Astrid Paulus
Honoraria - Roche
 
Marius Zemaitis
Consulting or Advisory Role - AstraZeneca; Janssen; MSD; Swixx BioPharma
Speakers' Bureau - AstraZeneca; Lilly O.; MSD; Roche; Swixx BioPharma
 
Saulius Cicenas
Speakers' Bureau - MSD
Travel, Accommodations, Expenses - Roche
 
Zanete Zvirbule
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BerGenBio; Bristol Myers Squibb; Daiichi Sankyo Europe GmbH; F. Hoffmann LaRoche; GlaxoSmithKline; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Peptomyc; Pfizer; Sanofi; Takeda; Turning Point Therapeutics
Speakers' Bureau - Amgen; AstraZeneca; Bristol Myers Squibb; F. Hoffmann LaRoche; Janssen; Lilly; Medical Trends; Medscape; Merck Serono; Merck Sharp & Dohme; PeerVoice; Pfizer; Sanofi; Takeda; Touch Oncology
Research Funding - Merck (Inst); Merck KGaA (Inst)
Other Relationship - GRIFOLS
 
Annika Sanfridson
Employment - Cantargia AB
Stock and Other Ownership Interests - Cantargia AB
 
Camilla Rydberg-Millrud
Employment - Cantargia AB
Stock and Other Ownership Interests - Cantargia AB
Patents, Royalties, Other Intellectual Property - Cantargia AB
 
Susanne Magnusson
Employment - Cantargia AB
Stock and Other Ownership Interests - Cantargia AB
 
Nedjad Losic
Employment - Cantargia AB
Stock and Other Ownership Interests - Cantargia AB
 
Ignacio Garcia-Ribas
Employment - Cantargia AB
Stock and Other Ownership Interests - Cantargia AB; Sanofi
Honoraria - Oncomatryx
Consulting or Advisory Role - Cantargia AB; Shionogi; TFS; Triact Therapeutics; Zumutor Biologics